Thus, regulation of reversible protein-SSG formation has become a central issue in inflammatory responses and neurodegenerative diseases [1, 2], focusing attention on the enzyme glutaredoxin (Grx1). This evidence concerns the gene GLRX and neurodegenerative disease.